De Luca, Michele http://orcid.org/0000-0002-0850-8445
Aiuti, Alessandro
Cossu, Giulio
Parmar, Malin http://orcid.org/0000-0001-5002-4199
Pellegrini, Graziella
Robey, Pamela Gehron
Article History
Received: 6 August 2018
Accepted: 9 May 2019
First Online: 17 June 2019
Competing interests
: M.D.L. and G.P. are members of the Board of Directors of Holostem Terapie Avanzate Srl and consultant at J-TEC Ltd, Japan Tissue Engineering. A.A. is the principal investigator of clinical trials of HSC-GT for ADA-SCID, MLD and Wiskott–Aldrich, sponsored by Orchard Therapeutics. Orchard Therapeutic is the marketing authorization holder of Strimvelis in the European Union. M.P. is the owner of Parmar Cells AB and co-inventor of the US patent application 15/093,927 owned by Biolamina AB and EP17181588 owned by Miltenyi Biotec. M.P. is a New York Stem Cell Foundation Robertson Investigator.